Ambien doing well
Executive Summary
Pharmacia/Sanofi's U.S. sales of Ambien (zolpidem) were up 114% to $137 mil. in the first quarter. The growth was helped by trade purchases in advance of a price increase March 6, Pharmacia says. "Our goal is to maximize profitability as we prepare to return the rights to Sanofi-Synthelabo"